Authors: Hoag, SW Hussain, AS

Citation: Sw. Hoag et As. Hussain, The impact of formulation on bioavailability: Summary of workshop discussion, J NUTR, 131, 2001, pp. 1389S-1391S

Authors: Mahayni, H Rekhi, GS Uppoor, RS Marroum, P Hussain, AS Augsburger, LL Eddington, ND

Citation: H. Mahayni et al., Evaluation of "external" predictability of an in vitro-in vivo correlationfor an extended-release formulation containing metoprolol tartrate, J PHARM SCI, 89(10), 2000, pp. 1354-1361

Authors: Kaus, LC Gillespie, WR Hussain, AS Amidon, GL

Citation: Lc. Kaus et al., The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities, PHARM RES, 16(2), 1999, pp. 272-280

Authors: Rekhi, GS Nellore, RV Hussain, AS Tillman, LG Malinowski, HJ Augsburger, LL

Citation: Gs. Rekhi et al., Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets, J CONTR REL, 59(3), 1999, pp. 327-342

Authors: Hussain, AS Crispino, NH McLaughlin, BE Brien, JF Marks, GS Nakatsu, K

Citation: As. Hussain et al., Glyceryl trinitrate-induced vasodilation is inhibited by ultraviolet irradiation despite enhanced nitric oxide generation: Evidence for formation of a nitric oxide conjugate, J PHARM EXP, 289(2), 1999, pp. 895-900